Unlock instant, AI-driven research and patent intelligence for your innovation.

A human and mammalian cell attachment expression vector, construction method and application

An expression vector and mammalian technology, applied in the field of genetic engineering and gene therapy, can solve the problems of unstable gene expression, low copy number, low gene expression level, etc., and achieve the effect of stable expression

Active Publication Date: 2020-07-10
河南普诺易生物制品研究院有限公司 +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, studies have found that the CMV promoter carried by the vector pEGFP-C1-MAR itself drives the unstable expression of foreign genes, with low copy number and low gene expression level, and the promoter is derived from human cytomegalovirus, which has potential carcinogenic risks

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A human and mammalian cell attachment expression vector, construction method and application
  • A human and mammalian cell attachment expression vector, construction method and application
  • A human and mammalian cell attachment expression vector, construction method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] A method for constructing expression vectors for human and mammalian cell attachments, comprising:

[0032] 1. Synthesis of MAR sequence

[0033] The characteristic element (AT-rich sequence) of human β-interferon MAR sequence (GenBank accession number: M83137.1) and human β-globin MAR sequence (GenBank accession number: L22754.1) was cut and spliced ​​to obtain the nucleus The characteristic sequence of the matrix binding region (MAR, shown as SEQ ID NO: 1).

[0034] 2. Synthesis of EF-1α promoter sequence

[0035] The EF-1α promoter sequence (shown as SEQ ID NO: 2) was synthesized by General Biosystems (Anhui) Co., Ltd. In order to realize directional cloning, Ase I restriction sites (5′-ATTAAT -3') and Nhe I restriction site (5'-GCTAGC-3').

[0036] 3. Construction of pEGFP-C1-MAR vector

[0037] 1) Enzyme digestion reaction

[0038] Use Kpn Ⅰ and BamH Ⅰ double enzymes to digest the characteristic sequence of the nuclear matrix binding region and the pEGFP-C1 pl...

Embodiment 2

[0091] The construction of the pEME-NGF expression vector containing nerve growth factor (NGF), including:

[0092] 1. PCR amplification of NGF target fragment

[0093] According to the human NGF gene cDNA sequence (GenBank accession number: AF150960.1), PCR primers P7 and P8 (as shown in SEQ ID NO: 9-10) were designed. In order to realize directional cloning, the 5' ends of the primers were respectively introduced into HindⅢ, Kpn Ⅰ Restriction site (see underline), the primer sequence of NGF gene is:

[0094] P7: 5′-GCC AAGCTT ATGTCCATGTTGTTCTACACTCT-3';

[0095] P8: 5′-TTA GGTACC TCAGGCTCTTTCCACAGCCTTCCT-3'.

[0096] Take human peripheral blood, use a DNA extraction kit to extract human peripheral blood genomic DNA as a template, and use a conventional PCR amplification method for amplification. The PCR system is as follows: ddH 2 O 17.0 μL, P7, P8 (10 μmol / L) each 1.0 μL, 10×PCR buffer 2.5 μL, dNTP (25 μmol / L) 2.0 μL, DNA template (100ng / μL) 1.0 template DNA, Taq enz...

Embodiment 3

[0105] Establishment of pEME-NGF vector transfection CHO cell expression system, including:

[0106] CHO cells at 37°C, 5% CO 2 Under the condition, culture in DMEM medium containing 10% inactivated fetal bovine serum, the transfection method is carried out according to the instructions of the liposome 2000 transfection kit (the operation is the same as the above-mentioned test example), and after 24 hours of transfection, use 800 μg / mL The G418 culture medium was pressurized and screened for 2 weeks. After the stable transformed cell colony was formed, it was digested with 0.25% trypsin, and each group of transfected cells was limitedly diluted and monoclonalized. They were divided into 96-well culture plates and continued to culture for 7 days. Afterwards, transfer to a culture bottle to continue culturing, and when the cell density reaches 85% (80%-90% is acceptable), the cells can be collected.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a human and mammalian cell attachment expression vector, a construction method and application and belongs to the technical field of genetic engineering and gene therapy. The attachment expression vector containing a matrix attachment region characterized sequence (shown as SEQ ID NO: 1) is constructed by taking pEGFP-C1 as a starting vector, and an original CMV promoter on the pEGFP-C1 vector is replaced with an EF-1alpha promoter (shown as SEQ ID NO: 2) to obtain a pEME vector which can efficiently, continuously and stably express exogenous target genes.

Description

technical field [0001] The invention relates to a human and mammalian cell attachment expression vector, and also relates to a construction method and application of the attachment expression vector, belonging to the technical field of genetic engineering and gene therapy. Background technique [0002] Gene therapy refers to the technology of introducing normal genes or therapeutic DNA sequences into target cells in a certain way to correct gene defects or exert therapeutic effects so as to achieve the purpose of disease treatment. Since the first successful clinical trial of gene therapy in the early 1990s, thousands of clinical samples have been completed so far. As a form of molecular drug therapy, gene therapy provides a new treatment for many hereditary and acquired diseases, and has expanded from the treatment of early single-gene genetic diseases to the current multi-gene therapy that poses a serious threat to human health, including Malignant tumors, cardiovascular ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/85C12N15/66
CPCC12N15/66C12N15/85C12N2800/107
Inventor 王小引王天云杜爱玲贾岩龙赵春澎张俊河张玺高向征白可可孙彩霞
Owner 河南普诺易生物制品研究院有限公司